Pediatrix Medical Group Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, Pediatrix Medical Group stock has a consensus rating of "Hold" and an average price target of $30.08. The average 1-year stock price forecast is 3.93% lower than the current stock price, while the lowest is $28 (-10.57%) and the highest is $33.5 (+6.99%).

Price Target: $30.08 (-3.93%)

Analyst Consensus: Hold

Price Target

Chart

Target	Low	Average	Median	High
Price	$28	$30.08	$29.5	$33.5
Change	-10.57%	-3.93%	-5.78%	+6.99%

Analyst Ratings

The average analyst rating for Pediatrix Medical Group stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Chart

Rating	May '26	Jun '26	Jul '26	Aug '26	Sep '26	Oct '26
Strong Buy	2	2	2	1	1	1
Buy	0	0	0	0	0	0
Hold	5	5	5	6	6	6
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	7	7	7	7	7	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Unknown Analyst Leerink Partners No rating	Leerink Partners	Hold Maintains $21 → $30	Hold	Maintains	$21 → $30	-4.18%	Nov 2, 2026
Jack Slevin Jefferies	Jefferies	Hold Downgrades $27 → $28	Hold	Downgrades	$27 → $28	-10.57%	Aug 19, 2026
Ann Hynes Mizuho Securities	Mizuho Securities	Hold Maintains $27 → $28	Hold	Maintains	$27 → $28	-10.57%	Aug 12, 2026
A.J. Rice UBS	UBS	Hold Maintains $25 → $28	Hold	Maintains	$25 → $28	-10.57%	Aug 6, 2026
David S Macdonald Truist Financial	Truist Financial	Hold Maintains $28	Hold	Maintains	$28	-10.57%	Aug 5, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

1.97B

from 1.91B

2.81%

from 1.91B

Revenue Next Year

2.01B

from 1.97B

2.23%

from 1.97B

EPS This Year

2.38

from 2.04

16.90%

from 2.04

EPS Next Year

2.47

from 2.38

3.70%

from 2.38

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	1.91B	1.97B	1.99B	2.01B	1.91B	1.97B
Revenue Growth	10.22%	3.18%	1.15%	0.92%	-4.92%	2.81%
Gross Profit	513.24M	467.03M	421.57M	454.34M	493.70M	517.47M
Gross Margin	26.85%	23.68%	21.13%	22.57%	25.80%	26.30%
Operating Income	217.74M	200.00M	157.85M	183.68M	231.09M	248.00M
Net Income	130.96M	66.34M	-60.41M	-99.07M	165.39M	154.12M
EPS	-	-	-	-	2.04	2.38
EPS Growth	-	-	-	-	35.10%	16.90%
Forward PE	16.25	8.29	7.40	8.86	9.92	13.13
Free Cash Flow	-	-	-	-	252.63M	193.17M
No. Analysts	-	-	-	-	-	7

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	2.0B
Avg	2.0B
Low	2.0B

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	3.6%
Avg	2.8%
Low	2.1%

EPS Forecast

Chart

EPS	2026	2027	2028
High	2.43
Avg	2.38
Low	2.26

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	19.1%
Avg	16.9%
Low	10.8%